| Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents A Najmi, SA Javed, M Al Bratty, HA Alhazmi Molecules 27 (2), 349, 2022 | 233 | 2022 |
| FT-IR spectroscopy for the identification of binding sites and measurements of the binding interactions of important metal ions with bovine serum albumin HA Alhazmi Scientia Pharmaceutica 87 (1), 5, 2019 | 134 | 2019 |
| Thermophoresis for characterizing biomolecular interaction M Asmari, R Ratih, HA Alhazmi, S El Deeb Methods 146, 107-119, 2018 | 124 | 2018 |
| Medicinal plants and isolated molecules demonstrating immunomodulation activity as potential alternative therapies for viral diseases including COVID-19 HA Alhazmi, A Najmi, SA Javed, S Sultana, M Al Bratty, HA Makeen, ... Frontiers in immunology 12, 637553, 2021 | 102 | 2021 |
| Targeting peroxisome proliferator‐activated receptors using thiazolidinediones: strategy for design of novel antidiabetic drugs N Thangavel, M Al Bratty, S Akhtar Javed, W Ahsan, HA Alhazmi International journal of medicinal chemistry 2017 (1), 1069718, 2017 | 89 | 2017 |
| Phytochemical, Cytotoxic, and Antimicrobial Evaluation of the Fruits of Miswak Plant, Salvadora persica L. M Al Bratty, HA Makeen, HA Alhazmi, SM Syame, AN Abdalla, ... Journal of Chemistry 2020 (1), 4521951, 2020 | 78 | 2020 |
| Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review M Albratty, HA Alhazmi Arabian Journal of Chemistry 15 (6), 103846, 2022 | 75 | 2022 |
| Development and validation of LC–MS/MS method for simultaneous determination of metformin and four gliptins in human plasma M Al Bratty, HA Alhazmi, SA Javed, KG Lalitha, M Asmari, J Wölker, ... Chromatographia 80, 891-899, 2017 | 70 | 2017 |
| Treatment of SARS-CoV-2: How far have we reached? W Ahsan, S Javed, M Al Bratty, HA Alhazmi, A Najmi Drug discoveries & therapeutics 14 (2), 67-72, 2020 | 64 | 2020 |
| Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials B Mangla, S Javed, MH Sultan, P Kumar, K Kohli, A Najmi, HA Alhazmi, ... Phytotherapy Research 35 (10), 5440-5458, 2021 | 61 | 2021 |
| Cough suppressant herbal drugs: A review S Sultana, A Khan, MM Safhi, HA Alhazmi Int. J. Pharm. Sci. Invent 5 (5), 15-28, 2016 | 56 | 2016 |
| Data quality in drug discovery: the role of analytical performance in ligand binding assays H Wätzig, I Oltmann-Norden, F Steinicke, HA Alhazmi, M Nachbar, ... Journal of computer-aided molecular design 29, 847-865, 2015 | 51 | 2015 |
| Recent advances in affinity capillary electrophoresis for binding studies HM Albishri, SE Deeb, N AlGarabli, R AlAstal, HA Alhazmi, M Nachbar, ... Bioanalysis 6 (24), 3369-3392, 2014 | 51 | 2014 |
| Bioactive natural antivirals: An updated review of the available plants and isolated molecules S Mohan, MM Elhassan Taha, HA Makeen, HA Alhazmi, M Al Bratty, ... Molecules 25 (21), 4878, 2020 | 50 | 2020 |
| A comprehensive platform to investigate protein–metal ion interactions by affinity capillary electrophoresis HA Alhazmi, M Nachbar, HM Albishri, D Abd El-Hady, S Redweik, ... Journal of Pharmaceutical and Biomedical Analysis 107, 311-317, 2015 | 47 | 2015 |
| Nanoparticles of resveratrol attenuates oxidative stress and inflammation after ischemic stroke in rats M Ashafaq, MI Alam, A Khan, F Islam, G Khuwaja, S Hussain, R Ali, ... International Immunopharmacology 94, 107494, 2021 | 44 | 2021 |
| Metabolic stability assessment of new parp inhibitor talazoparib using validated lc–ms/ms methodology: In silico metabolic vulnerability and toxicity studies MW Attwa, AA Kadi, AS Abdelhameed, HA Alhazmi Drug design, development and therapy, 783-793, 2020 | 44 | 2020 |
| Synthesis and evaluation of some new 1, 3, 4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents M Albratty, KA El-Sharkawy, HA Alhazmi Acta pharmaceutica 69 (2), 261-276, 2019 | 41 | 2019 |
| Graphene-based biosensors for disease theranostics: Development, applications, and recent advancements HA Alhazmi, W Ahsan, B Mangla, S Javed, MZ Hassan, M Asmari, ... Nanotechnology Reviews 11 (1), 96-116, 2021 | 39 | 2021 |
| Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS MW Attwa, HW Darwish, HA Alhazmi, AA Kadi Clinica Chimica Acta 485, 298-304, 2018 | 39 | 2018 |
